Heidi Health Raises $65M Series B Led By Steve Cohen’s Point72 Private Investments
Dr. Tom Kelly, a trauma surgeon turned tech founder, saw firsthand how doctors were drowning in administrative work. His frustration sparked an idea that would reshape how clinicians interact with AI. That idea became Heidi Health, which today announced it has raised $65 million in a Series B round led by Steve Cohen’s Point72 Private Investments.
Image Credits:Heidi Health
The funding marks a major milestone for the healthtech startup, as it aims to transform clinical workflows with AI-powered tools that give doctors back precious time for patient care.
How Heidi Health Is Revolutionizing Medical Administration
Founded in 2021 by Dr. Kelly and co-founder Waleed Mussa, Heidi Health was built to empower doctors by automating repetitive, time-consuming tasks. The company’s flagship product is an AI medical scribe that manages administrative duties such as transcribing notes, summarizing patient interactions, and tracking follow-up tasks.
In just 18 months, the company reports having returned more than 18 million hours to frontline healthcare providers across 116 countries, impacting over 70 million patient visits.
AI Meets Healthcare: Building Smarter Clinical Tools
Heidi Health’s AI engine is model-agnostic, meaning it can operate using both its own proprietary technology and other large models like Gemini. This flexible approach enables better optimization across accuracy, latency, and cost.
“Our mission has always been about enabling clinicians to focus on care rather than admin,” said Dr. Kelly. “AI should feel like a partner, not a burden.”
Inside Heidi Health’s $65M Series B Investment
The newly raised $65 million Series B, led by Steve Cohen’s Point72 Private Investments, underscores growing investor confidence in AI healthcare solutions. Other participants in the round include Headline, Blackbird VC, Possible Ventures, and Archangel.
With this latest round, Heidi Health’s total funding reaches $96.6 million. The startup also announced key new hires, including former Microsoft Chief Medical Officer Dr. Simon Kos and Plaid’s head of revenue, Paul Williamson.
The company plans to use the fresh capital to accelerate product development and expand its suite of AI tools—such as a new AI agent that calls patients on behalf of doctors, reducing yet another layer of administrative friction.
Why Point72 Backed Heidi Health
According to Dr. Kelly, Point72 Private Investments was impressed not just by Heidi Health’s product but by its real-world adoption metrics.
“They had seen all the scribes before,” Dr. Kelly said. “But they’d never seen product adoption and usage metrics like ours. They loved that we’re obsessed with user experience, while most competitors focus on top-down sales.”
This user-first focus aligns with Point72’s strategy of supporting companies with strong product-market fit and measurable impact.
What’s Next for Heidi Health
With this new funding, Heidi Health aims to deepen its AI capabilities and expand its global reach. Dr. Kelly envisions a future where every clinician has a reliable AI partner by their side—one that minimizes burnout and maximizes patient outcomes.
As healthcare increasingly leans on technology, Heidi Health’s Series B success shows investors and practitioners alike that AI can make medicine more human, not less.
إرسال تعليق